For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises an awkward question that more people are now facing: what happens when you stop taking them?
This article was originally published on MedicalXpress.com

